-
More than 96% of ophthalmologists vaccinated: AAO
A survey from the American Academy of Ophthalmologists shows that more than 96 percent of ophthalmologists nationwide are vaccinated. -
How many ophthalmologists are still paying off their school loans? 4 stats
Three percent of ophthalmologists have a net worth of at least $5 million, according to Medscape. -
Michigan ASC joins PE-backed chain
Troy, Mich.-based TruVista Surgery Center joined Sunvera Group, a private equity-backed management services organization, according to a June 16 news release. -
Visus Therapeutics appoints 6 executive leaders
Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company. -
EyeSouth Partners appoints former Envision Healthcare leader as new CFO
Eye care group EyeSouth Partners introduced Kenneth Zongor as its next CFO, succeeding Jason Shafer, who will continue with the company as chief development officer, according to a June 15 press release. -
Columbia University selects endowed professor, director of pediatric ophthalmology
Columbia University in New York City recently introduced Steven E. Rosenberg, MD, as director of pediatric ophthalmology and the Anne S. Cohen Endowed Professor of Pediatric Ophthalmology. -
Alimera appoints chief retina specialist
Ophthalmic pharmaceutical company Alimera recently added David Dyer, MD, as its chief retina specialist. -
Michigan ophthalmology practice expands
Grand Rapids, Mich.-based Vitreo-Retinal Associates signed a 10-year lease on a space in Kalamazoo, RE Journals reported June 8. -
US Eye first to use new TECNIS Synergy lens
Sarasota, Fla.-based US Eye practices are the first to use Johnson & Johnson Vision's TECNIS Synerg Intraocular Lens for cataract surgery, the practice announced in a June 7 news release. -
Biotech company may earn $1.4B in ophthalmology, respiratory therapy deal
U.S. biotech company Pieris Pharmaceuticals partnered with Roche subsidiary Genentech for $20 million up front and may be eligible to receive more than $1.4 billion in additional milestone payments, The Pharma Letter reported May 25. -
10 ophthalmology industry updates for ASC leaders
Two ophthalmology clinics are opening in North Carolina, and private equity-backed ophthalmology companies are expanding. -
Duke Health opening eye clinic
Durham, N.C.-based Duke Health is opening an eye clinic on its campus in Morrisville, N.C., on May 24, according to a LinkedIn post. -
More than half of self-employed ophthalmologists saw patient volume drop in 2020: Medscape
In 2020, 64 percent of self-employed ophthalmologists experienced reduced patient volume, according to a compensation report by medical information company Medscape. -
Alabama eye surgery center on track for summer opening
Developers have finished the building structure for an ophthalmology ASC in Alabama. -
Aptinyx names newest member of board of directors
Biopharmaceutical company Aptinyx recently announced Joan Miller, MD, as a new addition to its board of directors. -
EyeSouth Partners snags 10th Georgia affiliation
Atlanta-based, private equity-backed EyeSouth Partners has completed its 10th affiliation in Georgia and its 23rd overall, according to a May 10 release. -
How ophthalmologist pay has changed in the past 10 years
Ophthalmology was hit hardest in the early stages of the pandemic, but average compensation rates remain steady. -
UC Davis Health's $62M ambulatory eye center expansion: 4 details
Sacramento, Calif.-based UC Davis Health is expanding its ophthalmology ambulatory care center, the Ernest E. Tschannen Eye Institute, located on its main campus. -
Ophthalmology outlook: Where practices are opening, breaking ground, renovating
A state list of ophthalmology centers that have opened or broken ground this year: -
Private equity in ophthalmology: 5 updates
Ophthalmology is no exception to the massive private equity push into healthcare. Here are five updates from PE-backed ophthalmology groups:
Page 35 of 46